← SynDRA
SURITOZOLE
SynDRA canonical compound SYN0001350 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ADORA1 | GABBR1 |
| Mechanism of action | GABA receptor inverse agonist |
All known targets
Mechanisms of action (all sources)
- GABA receptor inverse agonist
- GABRG3 MODULATOR
Cross-references
Synonyms
- Suritozol
- MDL 26,479
- MDL-26479
- MDL 26479
- 3H7H68317X
- suritozolum
- RefChem:932420
- DTXCID1071824
- 2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione
- 5-(3-fluorophenyl)-2,4-dimethyl-1,2,4-triazole-3-thione
- Suritozole [USAN:INN]
- BRN 6725971
- UNII-3H7H68317X
- MFCD00865375
- SURITOZOLE [INN]
- Suritozole (USAN/INN)
- SURITOZOLE [USAN]
- SURITOZOLE [WHO-DD]
- SCHEMBL121081
- orb1298825
- CHEBI:177573
- IWDUZEHNLHFBRZ-UHFFFAOYSA-N
- 5-(3-fluorophenyl)-2,4-dimethyl-3H-1,2,4-triazole-3-thione
- EBC-06503
- AKOS027201111
- TS-09827
- HY-114706
- CS-0064137
- NS00122394
- T8568
- D05980
- EN300-253548
- BRD-K98557884-001-01-6
- Z1509672221
- 5-(3-luorophenyl)-2,4-dimethyl-1,2,4-triazole-3-thione
- سوریتوزول
- 舒立托唑
- スリトゾール
Look up SURITOZOLE in the interactive SynDRA portal →